Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J U Gutterman

Showing results (61-70 of 333) with videos related to

Pageof 34
Sort By:
Journal of Interferon Research|August 1, 1989
Production of interferon-alpha induced by dsRNA in human peripheral blood mononuclear cell cultures: role of priming by dsRNA-induced interferons-gamma and -betaJ L Lepe-Zuniga, J Rotbein, J U Gutterman
Leukemia|April 1, 1987
Mid-term observations on the efficacy of alpha-interferon in hairy cell leukemia and status of the interferon system of patients in remissionJ R Quesada, J L Lepe-Zuniga, J U Gutterman
Hematologic Pathology|January 1, 1988
Tumor necrosis factor and human hematopoiesis: I. Kinetics and diversity of human bone marrow cell response to recombinant tumor necrosis factor alpha in short-term suspension cultures in vitroM Beran, S O'Brien, J U Gutterman, et al.
Cancer Research|February 15, 1988
Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor alpha and interleukin 2 in the generation of human lymphokine-activated killer cell cytotoxicityL B Owen-Schaub, J U Gutterman, E A Grimm
Medical and Pediatric Oncology|January 1, 1979
A study of transfer factor for opportunistic infections in cancer patientsS J Ketchel, V Rodriguez, A Stone, et al.
Archives of Dermatology|September 1, 1990
Necrotizing vasculitis at granulocyte-macrophage-colony-stimulating factor injection sitesK L Farmer, R Kurzrock, J U Gutterman, et al.
Important Advances in Oncology|January 1, 1988
Recent advances in the therapy of chronic myelogenous leukemiaM Talpaz, R Kurzrock, H M Kantarjian, et al.
Progress in Experimental Tumor Research|January 1, 1974
Tumor-directed immune reactivity and immunotherapy in malignant melanoma. Current statusG Mavligit, J U Gutterman, C McBride, et al.
The British Journal of Cancer. Supplement|March 1, 1975
New agents and combination chemotherapy of non-Hodgkin's lymphomaA T Skarin, E Frei, W C Moloney, et al.
Cancer Research|June 1, 1982
Modulation of natural killer cell-mediated cytotoxicity by partially purified and cloned interferon-alphaE Lotzová, C A Savary, J U Gutterman, et al.
Pageof 34

Showing results (61-70 of 333) with videos related to

Sort By:
Pageof 34
Journal of Interferon Research|August 1, 1989
Production of interferon-alpha induced by dsRNA in human peripheral blood mononuclear cell cultures: role of priming by dsRNA-induced interferons-gamma and -betaJ L Lepe-Zuniga, J Rotbein, J U Gutterman
Leukemia|April 1, 1987
Mid-term observations on the efficacy of alpha-interferon in hairy cell leukemia and status of the interferon system of patients in remissionJ R Quesada, J L Lepe-Zuniga, J U Gutterman
Hematologic Pathology|January 1, 1988
Tumor necrosis factor and human hematopoiesis: I. Kinetics and diversity of human bone marrow cell response to recombinant tumor necrosis factor alpha in short-term suspension cultures in vitroM Beran, S O'Brien, J U Gutterman, et al.
Cancer Research|February 15, 1988
Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor alpha and interleukin 2 in the generation of human lymphokine-activated killer cell cytotoxicityL B Owen-Schaub, J U Gutterman, E A Grimm
Medical and Pediatric Oncology|January 1, 1979
A study of transfer factor for opportunistic infections in cancer patientsS J Ketchel, V Rodriguez, A Stone, et al.
Archives of Dermatology|September 1, 1990
Necrotizing vasculitis at granulocyte-macrophage-colony-stimulating factor injection sitesK L Farmer, R Kurzrock, J U Gutterman, et al.
Important Advances in Oncology|January 1, 1988
Recent advances in the therapy of chronic myelogenous leukemiaM Talpaz, R Kurzrock, H M Kantarjian, et al.
Progress in Experimental Tumor Research|January 1, 1974
Tumor-directed immune reactivity and immunotherapy in malignant melanoma. Current statusG Mavligit, J U Gutterman, C McBride, et al.
The British Journal of Cancer. Supplement|March 1, 1975
New agents and combination chemotherapy of non-Hodgkin's lymphomaA T Skarin, E Frei, W C Moloney, et al.
Cancer Research|June 1, 1982
Modulation of natural killer cell-mediated cytotoxicity by partially purified and cloned interferon-alphaE Lotzová, C A Savary, J U Gutterman, et al.
Pageof 34